Table 2 Treatment and outcomes in the experimental group
Patient | Cycles of chemotherapy | Stopped | Reason for stopping | Extra-abdominal metastasis | Laparotomy | PCI | HIPEC | Current status |
|---|---|---|---|---|---|---|---|---|
1 | 1 | Yes | Toxicity | No | Yes | 15 | Yes, CC-0 | DOD |
2 | 6 | No | – | No | Yes | 26 | No | DOD |
3 | 6 | No | – | No | Yes | 7 | Yes, CC-0 | AWD |
4 | 6 | No | – | No | Yes | 19 | Yes, CC-0 | DOD |
5 | 3 | Yes | Progression | No | Yes | 35 | No | DOD |
6 | 6 | No | – | No | Yes | 9 | Yes, CC-0 | NED |
7 | 6 | No | – | No | Yes | 1 | Yes, CC-0 | NED |
8 | 6 | No | – | No | Yes | 4 | Yes, CC-0 | AWD |
9 | 3 | Yes | Progression | Yes | No | – | No | AWD |
10 | 6 | No | – | No | Yes | 15 | Yes, CC-0 | NED |
11 | 2 | Yes | Toxicity | No | Yes | 30 | No | DOD |
12 | 6 | Yes | – | No | Yes | 1 | Yes, CC-0 | NED |
13 | 1 | Yes | Progression | Yes | No | 17 | No | DOD |
14 | 4 | Yes | Toxicity | No | Yes | 18 | No | AWD |